The biggest M&A deal in India's drug industry for 2024, involving the acquisition of JB Chemicals, is on the verge of being withdrawn. Sources indicate that all contenders have either withdrawn or are considering canceling their plans. Anurag Joshi provided details on the matter. The Alkem promoter stake sale is aimed at the JB Chemicals bid.